Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CMS-D001 in Moderate-to-Severe Atopic Dermatitis (Phase II, China)
CTR20260084Phase 2Active
- Sponsor
- Hainan Demei Pharmaceutical Technology
- Start
- Jan 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of CMS-D001 in atopic dermatitis (AD), sponsored by Hainan Demei Pharmaceutical Technology. Started Jan 2026; status: active.
02
Drugs
CMS-D001
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on CTR20260084.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20260084.